Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the viral‐entry facilitators of SARS‐CoV‐2 as a therapeutic strategy in COVID‐19
Shibi Muralidar, Gayathri Gopal, Senthil Visaga Ambi
Journal of Medical Virology (2021) Vol. 93, Iss. 9, pp. 5260-5276
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

An update of anti-viral treatment of COVID-19
Serap Şimşek Yavuz, İpek Komşuoğlu Çelikyurt
TURKISH JOURNAL OF MEDICAL SCIENCES (2021) Vol. 51, Iss. SI-1, pp. 3372-3390
Open Access | Times Cited: 78
Comparative evaluation of authorized drugs for treating Covid‐19 patients
Towhidul Islam, Moynul Hasan, Mohammad Saydur Rahman, et al.
Health Science Reports (2022) Vol. 5, Iss. 4
Open Access | Times Cited: 38
COVID-19 receptor and malignant cancers: Association of CTSL expression with susceptibility to SARS-CoV-2
Lianmei Zhang, Chunli Wei, Dabing Li, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 6, pp. 2362-2371
Open Access | Times Cited: 29
Targeting the receptor binding domain and heparan sulfate binding for antiviral drug development against SARS-CoV-2 variants
Zi-Sin Yang, Tzong-Shiun Li, Yu-Sung Huang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Hypothesis: Emerging Roles for Aryl Hydrocarbon Receptor in Orchestrating CoV-2-Related Inflammation
Tiziana Guarnieri
Cells (2022) Vol. 11, Iss. 4, pp. 648-648
Open Access | Times Cited: 21
Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
Raahilah Zahir Essa, Yuan Seng Wu, Kalaivani Batumalaie, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1166-1181
Open Access | Times Cited: 20
Isolation, synthesis and structure–activity relationships of gallotannin derivatives as cathepsin C inhibitor
Hongying Liao, Liang-Mou Kuo, Wei-Ting Chen, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130133-130133
Closed Access
Exploring Gingerol Substructures as Potential SARS‐CoV‐2 RBD Inhibitors: An Integrated Machine Learning and In Silico Approach
D. R. Sherin, S. R. Linda, A. Akhila
ChemistrySelect (2025) Vol. 10, Iss. 15
Closed Access
Cathepsins and SARS‐CoV‐2 infection: From pathogenic factors to potential therapeutic targets
Shuxuan Zhao, Muzhou Jiang, Hong Qing, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 19, pp. 2455-2481
Closed Access | Times Cited: 8
SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening
Emiel Vanhulle, Joren Stroobants, Becky Provinciael, et al.
Antiviral Research (2022) Vol. 203, pp. 105342-105342
Open Access | Times Cited: 13
Phenothiazines Inhibit SARS-CoV-2 Entry through Targeting Spike Protein
Taizhen Liang, Shiqi Xiao, Ziyao Wu, et al.
Viruses (2023) Vol. 15, Iss. 8, pp. 1666-1666
Open Access | Times Cited: 7
SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2
Kabita Pandey, Arpan Acharya, Dhananjaya Pal, et al.
Antiviral Research (2024) Vol. 227, pp. 105904-105904
Closed Access | Times Cited: 2
Transplacental Transmission of SARS-CoV-2: A Narrative Review
Minh Tien Bui, Cam Anh Nguyen Le, Khanh Linh Duong, et al.
Medicina (2024) Vol. 60, Iss. 9, pp. 1517-1517
Open Access | Times Cited: 2
A comprehensive review of research advances in the study of lactoferrin to treat viral infections
Amna Shafqat, Maochen Li, Zakirullah Zakirullah, et al.
Life Sciences (2024), pp. 123340-123340
Closed Access | Times Cited: 2
Developing Cytokine Storm-Sensitive Therapeutic Strategy in COVID-19 Using 8P9R Chimeric Peptide and Soluble ACE2
Yasaman Nazerian, Kimia Vakili, Ali Ebrahimi, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 14
Synthetic lethality-based prediction of anti-SARS-CoV-2 targets
Lipika R. Pal, Kuoyuan Cheng, Nishanth Ulhas Nair, et al.
iScience (2022) Vol. 25, Iss. 5, pp. 104311-104311
Open Access | Times Cited: 9
Impact of TMPRSS2 Expression, Mutation Prognostics, and Small Molecule (CD, AD, TQ, and TQFL12) Inhibition on Pan-Cancer Tumors and Susceptibility to SARS-CoV-2
Jiewen Fu, Shuguang Liu, Qi Tan, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7413-7413
Open Access | Times Cited: 8
Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis
Baranca Buijsers, Marissa L. Maciej-Hulme, Maaike Jacobs, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 4
Hyperglycemia induced cathepsin L maturation linked to diabetic comorbidities and COVID-19 mortality
Qiong He, Miao-Miao Zhao, Ming-Jia Li, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 1
A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers
Wenqian Zhang, Jiewen Fu, Jiaman Du, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Conventional Understanding of SARS‐CoV‐2 Mpro and Common Strategies for Developing Its Inhibitors
Kun Zhou, Daquan Chen
ChemBioChem (2023) Vol. 24, Iss. 22
Closed Access | Times Cited: 3
The Potential of Anti-coronavirus Plant Secondary Metabolites in COVID-19 Drug Discovery as an Alternative to Repurposed Drugs: A Review
Zahra Alipour, Somayeh Zarezadeh, Ali Akbar Ghotbi-Ravandi
Planta Medica (2023) Vol. 90, Iss. 03, pp. 172-203
Closed Access | Times Cited: 3
Alamandine: Potential Protective Effects in SARS-CoV-2 Patients
Ava Soltani Hekmat, Kazem Javanmardi
Journal of the Renin-Angiotensin-Aldosterone System (2021) Vol. 2021
Open Access | Times Cited: 7
Glomerular endothelial glycocalyx-derived heparan sulfate inhibits glomerular leukocyte influx and attenuates experimental glomerulonephritis
Marissa L. Maciej-Hulme, Jasper J. van Gemst, Patience Sanderson, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top